Answers are grounded in this paper and cite their sources.
As a major cause of morbidity in systemic lupus erythematosus (SLE), the prognosis of lupus nephritis (LN) critically depends on early detection and timely intervention. However, current diagnostic approaches remain suboptimal: renal biopsy is invasive and unsuitable for longitudinal monitoring, while conventional urine tests lack sensitivity for early-stage disease. Here, we report a molecular imaging strategy designed to target the pathogenic DNA–anti-dsDNA antibody axis for non-invasive detection of LN. We engineered a gallium-68-labeled single-stranded DNA (ssDNA) probe ([ 68 Ga]Ga-NOTA-ssDNA) and evaluated its diagnostic performance and biosafety in the spontaneous MRL/lpr lupus mouse model. The probe showed disease-associated and sustained renal accumulation in 16-week-old diseased MRL/lpr mice, with progressively increasing kidney-to-background contrast. More importantly, [ 68 Ga]Ga-NOTA-ssDNA enabled detection of renal immune complex deposition as early as 10 weeks of age, preceding abnormalities in conventional renal function markers and positive findings in renal histology by approximately two weeks. Mechanistically, the ssDNA backbone demonstrated favorable biocompatibility, without exacerbating autoimmune phenotypes or inducing Toll-like receptor-mediated signaling pathways. In conclusion, this study establishes a robust proof-of-concept for pathology-targeted PET/CT imaging of immune complex deposition. By directly visualizing the disease-driving renal autoantibody deposition at the preclinical stage, prior to overt organ damage, this strategy shifts LN diagnosis to non-invasive, mechanism-based molecular visualization.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: